Year |
Citation |
Score |
2023 |
Li W, Zheng D, Zhang Y, Yang S, Su N, Bakhoum M, Zhang G, Naderinezhad S, Mao Z, Wang Z, Zhou T. Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST. Research Square. PMID 37886478 DOI: 10.21203/rs.3.rs-3270539/v1 |
0.35 |
|
2023 |
Naderinezhad S, Zhang G, Wang Z, Zheng D, Hulsurkar M, Bakhoum M, Su N, Yang H, Shen T, Li W. A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression. Cancer Letters. 571: 216333. PMID 37543278 DOI: 10.1016/j.canlet.2023.216333 |
0.335 |
|
2021 |
Wang Z, Hulsurkar M, Zhuo L, Xu J, Yang H, Naderinezhad S, Wang L, Zhang G, Ai N, Li L, Chang JT, Zhang S, Fazli L, Creighton CJ, Bai F, ... ... Li W, et al. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation. Neoplasia (New York, N.Y.). 23: 1147-1165. PMID 34706306 DOI: 10.1016/j.neo.2021.09.005 |
0.398 |
|
2019 |
Wang Z, Zhao Y, An Z, Li W. Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression. Frontiers in Oncology. 9: 1491. PMID 32039001 DOI: 10.3389/Fonc.2019.01491 |
0.423 |
|
2019 |
Zhang Y, Zheng D, Zhou T, Hulsurkar M, Ittmann M, Shao L, Gleave M, Li W. Abstract 186: Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-186 |
0.384 |
|
2018 |
Zhang Y, Zheng D, Zhou T, Song H, Hulsurkar M, Su N, Liu Y, Wang Z, Shao L, Ittmann M, Gleave M, Han H, Xu F, Liao W, Wang H, ... Li W, et al. Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers. Nature Communications. 9: 4080. PMID 30287808 DOI: 10.1038/S41467-018-06177-2 |
0.424 |
|
2018 |
Zhao Y, Li W. Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression. Asian Journal of Andrology. PMID 29848834 DOI: 10.4103/Aja.Aja_32_18 |
0.385 |
|
2018 |
Li L, Su N, Zhou T, Zheng D, Wang Z, Chen H, Yuan S, Li W. Mixed lineage kinase ZAK promotes epithelial-mesenchymal transition in cancer progression. Cell Death & Disease. 9: 143. PMID 29396440 DOI: 10.1038/S41419-017-0161-X |
0.467 |
|
2017 |
Zheng D, Hulsurkar M, Sang M, Zhang S, Xu J, Gleave M, Ittmann M, Li W. Abstract 1577: GRK3 is a direct target of ADT-induced CREB1 activation and it promotes neuroendocrine differentiation of prostate cancer cells Cancer Research. 77: 1577-1577. DOI: 10.1158/1538-7445.Am2017-1577 |
0.439 |
|
2016 |
Hulsurkar M, Li Z, Zhang Y, Li X, Zheng D, Li W. Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1. Oncogene. PMID 27641328 DOI: 10.1038/Onc.2016.319 |
0.347 |
|
2016 |
Sang M, Hulsurkar M, Zhang X, Song H, Zheng D, Zhang Y, Li M, Xu J, Zhang S, Ittmann M, Li W. GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells. Oncotarget. PMID 27191986 DOI: 10.18632/Oncotarget.9359 |
0.443 |
|
2016 |
Tseng H, Gage JA, Desai PK, Brobey R, Skinner S, Dehghani M, Rosenblatt KP, Li W, Amato RJ, Souza GR. Abstract 4251: Development of spheroids derived from tumor biopsies and patient-derived xenografts using magnetic 3D bioprinting Cancer Research. 76: 4251-4251. DOI: 10.1158/1538-7445.Am2016-4251 |
0.36 |
|
2015 |
Li L, Li W. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation. Pharmacology & Therapeutics. 150: 33-46. PMID 25595324 DOI: 10.1016/J.Pharmthera.2015.01.004 |
0.392 |
|
2015 |
Hulsurkar MM, Sang M, Song H, Li W. Abstract 4181: Chronic stress and beta adrenergic signaling promote angiogenesis and prostate cancer progression through suppressing the expression of Thrombospondin 1 Cancer Research. 75: 4181-4181. DOI: 10.1158/1538-7445.Am2015-4181 |
0.393 |
|
2015 |
Li L, Chang J, Du G, Amato R, Li W. Abstract 1433: CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression Cancer Research. 75: 1433-1433. DOI: 10.1158/1538-7445.Am2015-1433 |
0.44 |
|
2014 |
Li L, Liu C, Amato RJ, Chang JT, Du G, Li W. CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression. Oncotarget. 5: 10840-53. PMID 25333262 DOI: 10.18632/Oncotarget.2535 |
0.439 |
|
2014 |
Li W, Ai N, Wang S, Bhattacharya N, Vrbanac V, Collins M, Signoretti S, Hu Y, Boyce FM, Gravdal K, Halvorsen OJ, Nalwoga H, Akslen LA, Harlow E, Watnick RS. GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 111: 1521-6. PMID 24434559 DOI: 10.1073/Pnas.1320638111 |
0.479 |
|
2014 |
Ai N, Hulsurkar M, Akslen L, Watnick R, Harlow E, Li W. Abstract LB-189: GRK3 is essential for metastatic cells and promotes prostate cancer progression Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-189 |
0.495 |
|
2013 |
Li L, Ai N, Hulsurkar M, Li W. Abstract A57: Characterization of novel regulators of epithelial-mesenchymal transition in human cancer cells Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A57 |
0.474 |
|
2013 |
Li L, Lu E, Chang J, Li W. Abstract A160: Characterization of novel regulators for epithelial-mesenchymal transition. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A160 |
0.455 |
|
2012 |
Ai N, Harlow E, Li W. Abstract LB-90: Essential kinases for human metastatic cells pertaining to c-Met signaling Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-90 |
0.439 |
|
2010 |
Baldwin A, Grueneberg DA, Hellner K, Sawyer J, Grace M, Li W, Harlow E, Munger K. Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3. Proceedings of the National Academy of Sciences of the United States of America. 107: 12463-8. PMID 20616055 DOI: 10.1073/Pnas.1007462107 |
0.378 |
|
2009 |
Li W, Bhattacharya N, Boyce FM, Gupta P, Watnick RS, Harlow EE. Abstract A200: Differential kinase requirements of human cell lines pertaining to metastasis and c‐Met signaling Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A200 |
0.475 |
|
2008 |
Baldwin A, Li W, Grace M, Pearlberg J, Harlow E, Münger K, Grueneberg DA. Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 16478-83. PMID 18948598 DOI: 10.1073/Pnas.0806195105 |
0.36 |
|
2008 |
Grueneberg DA, Li W, Davies JE, Sawyer J, Pearlberg J, Harlow E. Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines. Proceedings of the National Academy of Sciences of the United States of America. 105: 16490-5. PMID 18948597 DOI: 10.1073/Pnas.0806578105 |
0.392 |
|
2008 |
Bommi-Reddy A, Almeciga I, Sawyer J, Geisen C, Li W, Harlow E, Kaelin WG, Grueneberg DA. Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen. Proceedings of the National Academy of Sciences of the United States of America. 105: 16484-9. PMID 18948595 DOI: 10.1073/Pnas.0806574105 |
0.398 |
|
2008 |
Grueneberg DA, Degot S, Pearlberg J, Li W, Davies JE, Baldwin A, Endege W, Doench J, Sawyer J, Hu Y, Boyce F, Xian J, Munger K, Harlow E. Kinase requirements in human cells: I. Comparing kinase requirements across various cell types. Proceedings of the National Academy of Sciences of the United States of America. 105: 16472-7. PMID 18948591 DOI: 10.1073/Pnas.0808019105 |
0.406 |
|
2007 |
Sengupta S, Kim KS, Berk MP, Oates R, Escobar P, Belinson J, Li W, Lindner DJ, Williams B, Xu Y. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion. Oncogene. 26: 2894-901. PMID 17130843 DOI: 10.1038/Sj.Onc.1210093 |
0.436 |
|
2006 |
Graham K, Li W, Williams BR, Fraizer G. Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells. Gene Expression. 13: 1-14. PMID 16572586 DOI: 10.3727/000000006783991953 |
0.365 |
|
2005 |
Pearlberg J, Degot S, Endege W, Park J, Davies J, Gelfand E, Sawyer J, Conery A, Doench J, Li W, Gonzalez L, Boyce FM, Brizuela L, Labaer J, Grueneberg D, et al. Screens using RNAi and cDNA expression as surrogates for genetics in mammalian tissue culture cells. Cold Spring Harbor Symposia On Quantitative Biology. 70: 449-59. PMID 16869783 DOI: 10.1101/Sqb.2005.70.047 |
0.311 |
|
2005 |
Li W, Kessler P, Williams BR. Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia. Oncogene. 24: 457-68. PMID 15531917 DOI: 10.1038/Sj.Onc.1208228 |
0.317 |
|
2004 |
Stanhope-Baker P, Kessler PM, Li W, Agarwal ML, Williams BR. The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53. The Journal of Biological Chemistry. 279: 33575-85. PMID 15155752 DOI: 10.1074/Jbc.M404787200 |
0.331 |
|
Show low-probability matches. |